nach oben

Applied Health Economics and Health Policy

Erschienen in:

01.03.2006 | Current Opinion

Recycling blood

Sharing the benefits of cell salvage

verfasst von: Bernard Crotty

Erschienen in: Applied Health Economics and Health Policy | Ausgabe 1/2006

Einloggen, um Zugang zu erhalten

Abstract

This paper examines the service-wide costs to the English NHS that are associated with a Hospital Trust expanding the utilisation of cell salvage techniques as an alternative to using donated blood collected from volunteer donors.

Costs in the respective NHS organisations should not be viewed in isolation. Significant savings can be realised by adopting a collaborative approach to expand the use of cell salvage techniques. In time, the associated increase in cell salvage utilisation will generate cost savings at the National Blood Service, with more immediate realisable savings arising within Hospital Trust budgets.

Laurance J. Blood in their hands? The Independent 2005 Feb 15; Health Section: 1

Council of Europe Report (2000). Autologous blood donation and transfusion in Europe, report of the 1997 DATA. Council of Europe website [online]. Available from URL: http://www.social.coe.int/en/qoflife/publi/autolog.htm [Accessed 2004 Jun 16]

Hill J, James V. Survey of autologous blood transfusion activity in England. Transfus Med 2003; 13: 9–15PubMedCrossRef

Varney S, Guest J. The annual cost of blood transfusions in the UK. Transfus Med 2003; 13: 205–18PubMedCrossRef

Health Service Circular HSC 1998/224. Better blood transfusion. London: Department of Health, 1998

Health Service Circular HSC 2002/009. Better blood transfusion: appropriate use of blood. London: Department of Health, 2002 [online]. Available from URL: http://www.dh.gov.uk/assetRoot/04/01/22/93/04012293.pdf [Accessed 2006 Apr 28]

Carless P, Henry D, Moxey A, et al. Cell salvage for minimising perioperative allogeneic blood transfusion (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 2. Oxford: Update Software, 2004

Vamvakas E, Blajchman M. Deleterious clinical effects of transfusion associated immunomodulation: fact or fiction? Blood 2001; 97(5): 1180–95PubMedCrossRef

Thomas D, Wareham K, Cohen D, et al. Autologous blood transfusion in total knee replacement surgery. Br J Anaesth 2001; 86: 669–73PubMedCrossRef

10.

Hughes J, Thomas D. Autologous blood transfusion in total knee replacement surgery [letter]. Br J Anaesth 2001; 87: 941PubMedCrossRef

11.

NHS costing manual. Version 4. London: Department of Health, 2003 [online]. Available from URL: http://www.dh.gov.uk/assetRoot/04/09/39/88/04093988.pdf [Accessed 2006 Apr 28]

12.

National Institute for Health and Clinical Excellence. Intraoperative blood cell salvage in obstetrics: understanding NICE guidelines. Information for people considering the procedure, and the public. IP Guidance Number: IPG144. London: NICE, 2005 Nov [online]. Available from URL: http://www.nice.org.uk/page.aspx?.o=IP_40 [Accessed 2006 Apr 28]

13.

Reference costs 2005. London: Department of Health UK, 2005 [online]. Available from URL: http://www.dh.gov.uk/asse-tRoot/04/13/32/25/04133225.xls [Accessed 2006 Apr 28]

Titel: Recycling blood
Sharing the benefits of cell salvage
verfasst von: Bernard Crotty
Publikationsdatum: 01.03.2006
Verlag: Springer International Publishing
Erschienen in: Applied Health Economics and Health Policy / Ausgabe 1/2006
Print ISSN: 1175-5652
Elektronische ISSN: 1179-1896
DOI: https://doi.org/10.2165/00148365-200605010-00002

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Recycling blood

Sharing the benefits of cell salvage

Abstract

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2006

Health reform, equity and primary healthcare

The relationship between ex ante mortality risk and end-of-life medical costs

Genetic health technology and economic evaluation

A macroeconomic approach to evaluating policies to contain antimicrobial resistance

Methodological aspects in the assessment of treatment effects in observational health outcomes studies

Using economic analyses for local priority setting